Ocera Therapeutics (OCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2011 | 03-2011 | 12-2010 | 09-2010 | 06-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 59,608 | 12,479 | 17,373 | N/A | N/A |
| Receivables | 1,384 | 1,598 | 1,354 | N/A | N/A |
| TOTAL | $63,201 | $15,261 | $19,224 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 1,215 | 1,272 | 1,302 | N/A | N/A |
| Other Non-Current Assets | 278 | 1,682 | 1,068 | 0 | 0 |
| TOTAL | $1,493 | $2,954 | $2,370 | $N/A | $N/A |
| Total Assets | $64,694 | $18,215 | $21,594 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,133 | 2,796 | 806 | 0 | 0 |
| Accrued Expenses | 1,559 | 1,019 | 1,165 | N/A | N/A |
| TOTAL | $15,983 | $14,163 | $11,068 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 8,635 | 9,809 | 10,951 | N/A | N/A |
| Deferred Revenues | 7,001 | 7,292 | 7,243 | N/A | N/A |
| Other Non-Current Liabilities | 192 | 274 | 464 | 0 | 0 |
| TOTAL | $10,473 | $13,261 | $16,465 | $N/A | $N/A |
| Total Liabilities | $26,456 | $27,424 | $27,533 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,046 | 12 | N/A | N/A | N/A |
| Retained earnings | -92,194 | -87,787 | -84,422 | N/A | N/A |
| Other shareholders' equity | -655 | -632 | -667 | 0 | 0 |
| TOTAL | $38,238 | $-9,209 | $-5,939 | $N/A | $N/A |
| Total Liabilities And Equity | $64,694 | $18,215 | $21,594 | $0 | $0 |